At Advanced Therapies Week 2024, the Association for the Advancement of Blood & Biotherapies (AABB) invited industry leaders to convene for a roundtable to discuss ‘The Need for Well-Qualified Personnel.’

The Article summarizes the roundtable discussion, addressing the demand for qualified personnel in the cell and gene therapy industry. The participants, representing diverse industry roles, discussed challenges and the collective commitment to improving qualifications. They emphasized the need for transformative changes, considering factors like educational background and practical training. The article highlights the importance of standardized training programs, accreditation, and collaboration with industry associations. Key takeaways include the necessity for well-rounded leaders, the inadequacy of relying solely on education and experience, and the potential role of AABB’s Certified Advanced Biotherapies Professional (CABP) credential. The article concludes optimistically, foreseeing standardized training programs leading to a recognized and reliable workforce in the field.

This Article has been produced in partnership with AABB.